+

WO2013038534A1 - Procédé de détection d'un acide nucléique cible - Google Patents

Procédé de détection d'un acide nucléique cible Download PDF

Info

Publication number
WO2013038534A1
WO2013038534A1 PCT/JP2011/071048 JP2011071048W WO2013038534A1 WO 2013038534 A1 WO2013038534 A1 WO 2013038534A1 JP 2011071048 W JP2011071048 W JP 2011071048W WO 2013038534 A1 WO2013038534 A1 WO 2013038534A1
Authority
WO
WIPO (PCT)
Prior art keywords
sequence
nucleic acid
primer
target nucleic
dna
Prior art date
Application number
PCT/JP2011/071048
Other languages
English (en)
Japanese (ja)
Inventor
孝介 丹羽
廣田　寿一
三雄 川瀬
Original Assignee
日本碍子株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日本碍子株式会社 filed Critical 日本碍子株式会社
Priority to PCT/JP2011/071048 priority Critical patent/WO2013038534A1/fr
Priority to JP2013533406A priority patent/JP5932808B2/ja
Priority to JP2012173333A priority patent/JP6182300B2/ja
Priority to JP2012173361A priority patent/JP2013059320A/ja
Priority to JP2012175283A priority patent/JP6001374B2/ja
Priority to EP12832061.1A priority patent/EP2762562B1/fr
Priority to JP2012549585A priority patent/JP5503021B2/ja
Priority to ES12832061T priority patent/ES2736977T3/es
Priority to SG11201400635UA priority patent/SG11201400635UA/en
Priority to PCT/JP2012/073710 priority patent/WO2013039228A1/fr
Priority to CN201280045065.7A priority patent/CN103797119B/zh
Priority to MYPI2014000740A priority patent/MY157586A/en
Publication of WO2013038534A1 publication Critical patent/WO2013038534A1/fr
Priority to JP2014023882A priority patent/JP6076273B2/ja
Priority to US14/208,070 priority patent/US20140206567A1/en
Priority to US15/820,798 priority patent/US20180119211A1/en
Priority to JP2018073278A priority patent/JP2018143245A/ja
Priority to JP2021051302A priority patent/JP2021100429A/ja

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/161—Modifications characterised by incorporating target specific and non-target specific sites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/125—Sandwich assay format
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/149—Particles, e.g. beads
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/179—Nucleic acid detection characterized by the use of physical, structural and functional properties the label being a nucleic acid

Definitions

  • the present invention relates to a technique for detecting a target nucleic acid.
  • nucleic acid sequences have been proposed as methods for genetic analysis of living organisms and for examining the presence of viruses, bacteria, and the like in biological samples.
  • a probe or the like associated with a target nucleic acid sequence is prepared in advance, and hybridization between the probe and the like and a DNA fragment amplified from a biological sample by a nucleic acid amplification method is used.
  • the target nucleic acid is detected with a labeling substance that has been bound to the fragment.
  • a method is described in which a primer is designed to include a base sequence that allows a specific substance to bind to both ends of a DNA fragment amplified by a nucleic acid amplification method, and the DNA fragment is detected using such a specific substance.
  • Patent Document 1 a method is described in which a primer is designed to include a base sequence that allows a specific substance to bind to both ends of a DNA fragment amplified by a nucleic acid amplification method, and the DNA fragment is detected using such a specific substance.
  • Patent Documents 2 and 3 Non-Patent Document 1
  • a sample preparation step is designed so that a detection probe having an artificial base sequence is prepared in advance and a DNA fragment having a base sequence that binds to the artificial base sequence can be amplified.
  • a specific substance recognizes a specific substance binding site (specific base sequence to which a specific substance can bind) of an amplified DNA fragment and binds to the specific base sequence.
  • the amplified DNA fragment forms a double strand with its complementary strand even in its specific base sequence, and is not in a single-stranded state that easily interacts with a specific substance. Therefore, the efficiency with which a specific substance recognizes a specific base sequence is not so high, and it is necessary to concentrate double-stranded fragments to which the specific substance is bound.
  • amplification is performed on the array intentionally by performing amplification with a relatively high concentration of one primer (also referred to as asymmetric PCR) in the labeling step.
  • the reactivity is improved by selectively amplifying the DNA strand that reacts with the probe.
  • non-contrast PCR tended to reduce the amplification efficiency itself.
  • a DNA amplification fragment used as a sample is also a double strand, and in order to efficiently perform hybridization with a probe, it is subjected to heat denaturation or alkali denaturation to be single stranded. It is common to do. However, the denatured amplified fragment gradually returns to double strand, which may reduce the hybridization efficiency. On the other hand, in order to suppress this, it may be necessary to optimize conditions such as hybridization time and temperature.
  • the present invention solves the problem of sample DNA fragments in conventional probe hybridization and realizes efficient probe hybridization, a target nucleic acid detection method, and a gene amplification agent and high
  • An object is to provide a composition for hybridization.
  • the present inventors examined modification of the nucleic acid amplification method from the viewpoint of improving hybridization efficiency and sensitivity with a probe when applied to probe hybridization. As a result of various studies, knowledge that hybridization efficiency is high and detection sensitivity can be improved by introducing a site capable of suppressing or stopping the progress of the polymerase reaction into a part of the primer used for nucleic acid amplification. Got. According to the present invention, the following means are provided based on this finding.
  • a method for detecting a target nucleic acid in a sample Preparing a solid phase body comprising detection probes each having a different predetermined base sequence; A tag sequence complementary to the detection probe previously associated with the target nucleic acid, and a first identification sequence for identifying a first base sequence in the target nucleic acid, the tag sequence and the first recognition
  • a second primer comprising a second identification sequence for identifying a second base sequence in the target nucleic acid
  • a method comprising: (2) The method according to (1), wherein the second primer has a labeling substance binding region to which
  • the amplification step is a step of performing nucleic acid amplification using a nucleoside triphosphate including a nucleoside derivative triphosphate having a labeling substance.
  • the linking site does not include a natural base or a derivative of a natural base paired with a natural base.
  • the linking site includes an alkylene chain or a polyoxyalkylene chain which is adjacent to the nucleotide in the primer via a phosphodiester bond and has 2 to 40 elements and may be substituted.
  • nucleic acid amplification is performed using a plurality of sets of the first primer and the second primer so as to be detectable by a plurality of the detection probes previously associated with the plurality of target nucleic acids.
  • the hybridization step is a step of bringing the plurality of amplified fragments obtained in the amplification step into contact with the plurality of detection probes on the solid phase so as to be capable of hybridizing
  • the detection step is a step of detecting a hybrid product of the plurality of amplified fragments on the solid phase body and the plurality of detection probes.
  • the tag sequence has 20 to 50 bases.
  • (13) including a first arbitrary base sequence from the 5 ′ side and a first identification sequence for identifying the first base sequence in the nucleic acid to be amplified, the first arbitrary base sequence and the first
  • a nucleic acid amplification agent used in a nucleic acid amplification method which is an oligonucleotide derivative having a linking site capable of suppressing or stopping a DNA polymerase reaction between 1 and a recognition sequence.
  • a nucleic acid amplification kit comprising two or more nucleic acid amplification agents according to (13) or (14).
  • a composition for probe hybridization comprising a DNA double-stranded fragment.
  • the probe hybridization composition according to (16) wherein the other strand has a single-stranded portion on the 5 ′ side, and a label is linked to the single-stranded portion.
  • a method for amplifying a target nucleic acid in a sample Including a first arbitrary base sequence and a first identification sequence for identifying the first base sequence in the target nucleic acid, between the first arbitrary base sequence and the first identification sequence, Performing nucleic acid amplification of the sample using at least a first primer having a linking site capable of suppressing or terminating the DNA polymerase reaction, A method of providing.
  • the present invention relates to a method for detecting a target nucleic acid, a nucleic acid amplification agent, and the like.
  • the target nucleic acid detection method of the present invention is characterized by using the following first primer and second primer.
  • An example of the amplification step in the detection method of the present invention is shown in FIGS. 1A and 1B.
  • the first primer discriminates the first arbitrary base sequence such as a tag sequence complementary to the detection probe previously associated with the target nucleic acid from the first base sequence in the target nucleic acid.
  • a linking site capable of suppressing or stopping the DNA polymerase reaction between the first arbitrary base sequence and the first recognition sequence,
  • the second primer includes a second identification sequence that identifies the second base sequence in the target nucleic acid.
  • the linking site suppresses or stops the DNA polymerase reaction. That is, the linking site cannot be a template for a DNA extension reaction by DNA polymerase because it does not contain a natural base or the like. Therefore, as shown in FIG. 1A, when the DNA single strand amplified by the first primer becomes a template strand and further amplified by the second primer, the DNA extension reaction from the second primer is In addition, it is suppressed or stopped on the 3 ′ side from the site that matches the linking site. Therefore, as a result, the amplified fragment (DNA double-stranded fragment) obtained by the amplification step is provided with a first arbitrary base sequence protruding from one end as a single strand and double-paired by base pairing. It is inferred to have a chain part.
  • FIG. 1B also shows a case where the second primer further has a second arbitrary base sequence, and has the linking site between the second arbitrary base sequence and the second identification sequence.
  • An amplification process is shown.
  • FIG. 1B like the first primer shown in FIG. 1A, when the DNA single strand amplified by the second primer becomes a template strand and further amplified by the first primer, The DNA extension reaction from one primer is suppressed or stopped on the 3 ′ side from the site that pairs with the ligation site.
  • the amplified fragment (DNA double-stranded fragment) obtained by the amplification step is provided as a single strand with a tag sequence protruding at one end and an arbitrary base sequence protruding at the other end. It is inferred that it is provided as a single strand and has a double-stranded portion by base pairing.
  • the target nucleic acid can be detected with extremely high sensitivity and speed when the amplified fragment obtained by carrying out the step is hybridized with the detection probe without being denatured as it is.
  • the obtained DNA double-stranded fragment forms a double-stranded portion in the first base sequence and the second base sequence in the target nucleic acid, and a tag sequence at the end. Since it is a DNA double-stranded fragment possessed as a single strand, it is considered that this single strand is efficiently hybridized with the probe. Sensitivity improves as hybridization efficiency increases.
  • Such an oligonucleotide derivative having a base sequence including a linking site is useful as a nucleic acid amplification agent such as a primer itself.
  • the nucleic acid amplification method using such a primer, the obtained DNA double-stranded fragment and the hybridization composition containing the fragment can also exhibit at least one effect corresponding to the form of each.
  • nucleic acid refers to all DNA and RNA including cDNA, genomic DNA, synthetic DNA, mRNA, total RNA, hnRNA and synthetic RNA, peptide nucleic acid, morpholino nucleic acid, methylphosphonate nucleic acid, and Includes artificially synthesized nucleic acids such as S-oligonucleic acid. Moreover, it may be single-stranded or double-stranded.
  • target nucleic acid is an arbitrary nucleic acid having an arbitrary sequence.
  • nucleic acids may have a base sequence that serves as a genetic indicator in humans or non-human animals, such as constitution, genetic disease, onset of specific diseases such as cancer, disease diagnosis, treatment prognosis, drug and treatment selection, etc.
  • nucleic acids with Examples of the index include polymorphisms such as SNP and congenital or acquired mutations.
  • nucleic acids derived from microorganisms such as pathogenic bacteria and viruses are also included in the target nucleic acid.
  • a sample described later or a nucleic acid fraction thereof can be used as it is, but preferably, an amplification product obtained by amplifying a plurality of target nucleic acids by PCR amplification reaction, more preferably multiplex PCR amplification reaction is used. It is preferable to use it.
  • sample refers to a sample that may contain a target nucleic acid.
  • Samples include cells, tissues, blood, urine, saliva and the like, and any sample containing nucleic acid can be used. Fractions containing nucleic acids from these various samples can be obtained by those skilled in the art with reference to conventional techniques as appropriate.
  • the “target sequence” refers to a sequence composed of one or more bases characteristic of the target nucleic acid to be detected.
  • it may be a partial sequence with low homology between target nucleic acids, or may be a sequence that is complementary or has low homology to other nucleic acids that may be contained in a sample.
  • the target sequence may be a sequence characteristic of the target nucleic acid.
  • Such target sequences may be artificially altered sequences.
  • the detection method disclosed in the present specification includes a step of preparing a solid phase body provided with a detection probe, and a step of performing nucleic acid amplification of the sample using a first primer and a second primer.
  • a detection step for detecting a hybridized product is provided.
  • the detection method disclosed in the present specification applies to one or more types of target nucleic acids, and more specifically, target sequences related to characteristic sequences in these target nucleic acids are to be detected.
  • a series of steps for one kind of target nucleic acid will be mainly described. However, the following steps are also applied to a case where a plurality of target nucleic acids are detected simultaneously.
  • the detection method disclosed in the present specification can include a step of preparing a solid phase as shown in FIG. 2A.
  • a solid phase may be prepared in advance prior to the execution of the detection method, may be obtained commercially, or may be prepared each time the detection method is performed.
  • the solid phase body can be provided with a plurality of detection probes each having a detection sequence that is a different unique base sequence on a carrier.
  • a detection probe each having a detection sequence that is a different unique base sequence on a carrier.
  • FIG. 2A shows an example of a solid phase body.
  • Each of the detection probes has a detection sequence that is a unique base sequence for probing.
  • a detection sequence can be set independently of the sequence characteristic of the target nucleic acid, that is, the target sequence.
  • the detection sequence of the detection probe can suppress or avoid non-specific binding between a plurality of detection probes, and is suitable for hybridization at a suitable temperature and time. Can be set in consideration of the hybridization conditions.
  • the same detection probe can always be used regardless of the type of target nucleic acid.
  • the length of the detection sequence is not particularly limited, but is preferably 20 bases or more and 50 bases or less. This is because within this range, hybridization efficiency can be ensured while ensuring the specificity of each detection sequence.
  • a base length detection sequence includes a 46 base length sequence obtained by combining two base sequences each having a base length of 23 bases each selected from SEQ ID NOs: 1 to 100 and a complementary sequence thereof, and the combined base sequence. Can be obtained by appropriately adding or deleting a base. More preferably, it is 20 bases or more and 25 bases or less.
  • such a base length detection sequence can be obtained by appropriately adding or deleting bases to the 23 base length sequences of SEQ ID NOS: 1 to 100 and their complementary sequences or these base sequences. it can.
  • the tag sequence in the first primer is a base sequence that is paired with the detection sequence
  • the base length of the tag sequence is preferably 20 bases or more and 50 bases or less, like the detection sequence. Preferably, it is 20 bases or more and 25 bases or less.
  • the detection sequence of such a detection probe for example, the base sequence described in SEQ ID NO: 1 to SEQ ID NO: 100 or a base sequence complementary to this base sequence can be used. These base sequences all have the same base length (23 base length), and have a melting temperature (Tm) of 40 ° C. or higher and 80 ° C. or lower, preferably 50 ° C. or higher and 70 ° C. or lower, and are homogeneous in hybridization under the same conditions. A hybrid result can be obtained.
  • Tm melting temperature
  • 2 types selected from these base sequence groups can also be combined.
  • bases can be added, deleted, substituted, etc. within such a range that the specificity is not lost.
  • the detection sequence for the detection probe used at the same time is selected from the group of the base sequences (groups) represented by SEQ ID NOs: 1 to 100 or the complementary base sequence (group) to these. Is preferred.
  • the detection sequence of the detection probe can be appropriately selected from such candidate base sequences or their complementary sequences, and is selected from the base sequences shown in the following table or their complementary sequences. Only a probe set consisting of only one or two or more probes each having one or two or more base sequences as a detection sequence, or only a probe having all the following base sequences or their complementary sequences as detection sequences It is preferable to use a probe set consisting of By selecting such a base sequence as a detection sequence, it is possible to perform hybridization in a short time and realize further rapid hybridization.
  • the detection sequence in such a detection probe is also referred to as an orthonormalized sequence, for example, a continuous match length for a DNA sequence of a predetermined base length obtained from a random number, melting temperature prediction by Nearest-Neighbor method, Hamming distance, Designed by performing secondary structure prediction calculations.
  • the orthonormalized sequence is a base sequence of nucleic acid having a uniform melting temperature, that is, a sequence designed so that the melting temperature is within a certain range, and the nucleic acid itself is intramolecular. It means a base sequence that does not form a stable hybrid other than a base sequence that is structured in the above and does not inhibit hybridization with a complementary sequence.
  • a sequence included in one orthonormalized sequence group hardly reacts between sequences other than the desired combination and within a self-sequence, or does not generate a reaction. Further, when the orthonormalized sequence is amplified in PCR, the amount of nucleic acid corresponding to the initial amount of the nucleic acid having the orthonormalized sequence is quantitatively affected without being affected by the problems such as the above-mentioned cross-hybridization. Has the property of being amplified.
  • the orthonormalized array as described above is described in detail in H. Yoshida and A.Suyama, “Solution to 3-SAT by breadth first search”, DIMACS Vl.54, 9-20 (2000) and Japanese Patent Application No. 2003-108126. Are listed. Orthonormalized sequences can be designed using the methods described in these references.
  • the detection probe is immobilized on a carrier.
  • a solid phase carrier can be used.
  • the carrier may be plastic or glass, and the material is not particularly limited.
  • carrier may be flat form as shown in FIG. 1, it may be bead shape and a shape is not specifically limited.
  • the solid phase is preferably an array (particularly a microarray) in which the carrier is in the form of a solid plate and a plurality of detection probes are fixed in a fixed arrangement. The array can fix a large number of detection probes 4 and is convenient for comprehensively detecting various target nucleic acids at the same time.
  • the solid phase body may include a plurality of partitioned array regions on the carrier.
  • a set of detection probes each having the same combination may be fixed, or a set of detection probes each having a different combination may be fixed. If different combinations of detection probe sets are immobilized on multiple array regions, individual array regions can be assigned for detection of target nucleic acids in different genes.
  • the immobilization form of the detection probe is not particularly limited.
  • the 3 'end of the detection probe may be bound to a carrier, or the 5' end may be bound. It may be covalent or non-covalent.
  • the detection probe can be immobilized on the surface of the carrier by various conventionally known methods.
  • An appropriate linker sequence may be provided on the surface of the carrier. The linker sequence is preferably the same sequence with the same base length between the detection probes.
  • the amplification step is performed using a first primer and a second primer.
  • the nucleic acid amplification method in the nucleic acid amplification step include various known methods for amplifying DNA using a DNA polymerase reaction such as PCR to obtain a double-stranded DNA fragment.
  • the first primer includes a tag sequence complementary to a detection probe previously associated with the target nucleic acid and a first identification sequence for identifying the first base sequence in the target nucleic acid.
  • the lengths and the like of these base sequences are not particularly limited, and are appropriately determined according to the contents of the target sequence of the target nucleic acid.
  • the first identification sequence is a sequence for amplifying the target nucleic acid by nucleic acid amplification, and can specifically hybridize with the first base sequence constituting a part of the target sequence in the target nucleic acid.
  • the first identification sequence is set complementarily to the extent that it can hybridize with the first base sequence with high selectivity. Preferably, it is set to be completely complementary (specific).
  • the tag sequence is a sequence for allowing the amplified fragment to hybridize with the detection probe and detects the target nucleic acid. Therefore, the tag sequence hybridizes to the detection sequence of the detection probe for each target nucleic acid. It is set to be able to soy.
  • the base sequence is complementary to the detection sequence. Therefore, one target nucleic acid is associated with one detection probe.
  • the base length of the tag sequence preferably matches the base length of the detection sequence of the detection probe, preferably 20 bases to 50 bases, more preferably 20 bases to 25 bases. It is as follows.
  • the first base sequence and the second base sequence in the target nucleic acid may have any configuration with respect to the target nucleic acid.
  • only one of the base sequences may contain a mutation site of one or more bases, or both may contain a mutation site.
  • the first primer has such a tag sequence and a first identification sequence, has a natural base constituting such a base sequence or an artificial base homologous thereto, and a base pair with a natural nucleic acid. It has a skeleton that can be combined. Typically an oligonucleotide or a derivative thereof.
  • the ligation site is a site capable of suppressing or stopping the DNA polymerase reaction when included in the template strand.
  • the DNA polymerase reaction it is said that if there is no nucleic acid (or base) as a template, the DNA strand will not be extended any further.
  • the linking site of the present invention has a structure that cannot serve as a template during DNA elongation by DNA polymerase. That is, this linking site does not include a natural base or a derivative of a natural base (such as a natural base) that pairs with a natural base.
  • this linking site may be only a skeleton chain having no natural base or the like. That is, it may be a sugar-phosphate skeleton or a skeleton applied to other known artificial oligonucleotides.
  • the DNA polymerase includes various known DNA polymerases. Typically, DNA polymerase used for nucleic acid amplification methods, such as various PCR, is mentioned.
  • this linking site may be a chain linking group containing a single chain structure having 2 to 40 elements adjacent to the nucleotide via a phosphodiester bond. This is because if the number of elements is 1 or less, the DNA polymerase reaction is likely to be incompletely inhibited or stopped, and if the number of elements exceeds 40, the solubility of nucleotides may be reduced. Considering the effect of suppressing or stopping the DNA polymerase reaction, the chain linking group element is preferably 2 or more and 36 or less, more preferably 3 or more and 16 or less.
  • This linking site contains a single bond to facilitate rotation at the linking site, and the single bond is a carbon-carbon single bond, carbon-oxygen single bond, carbon-nitrogen single bond, SS single bond. Examples include bonding. It is preferable that this connection site is mainly composed of such a single bond. In addition, this linking site may partially contain an aromatic ring or cycloalkane as long as it contains a single bond.
  • the connecting site preferably contains an alkylene chain or a polyoxyalkylene chain which has 2 to 40 elements and may be substituted.
  • Such a chain-like connection structure is structurally simple and can be easily introduced as a connection site.
  • connection part represented by the following formula
  • equation (1) is mentioned, for example.
  • equation (1) (In the formula, 5 ′ represents an oxygen atom of a phosphodiester bond on the 5 ′ side, 3 ′ represents a phosphate atom of a phosphodiester bond on the 3 ′ side, and m represents an integer of 2 to 40. To express.),
  • m is preferably 2 or more and 36 or less, and more preferably 3 or more and 16 or less.
  • substituent of H in formula (1) include an alkyl group, an alkoxy group, and a hydroxyl group.
  • the alkyl group and alkoxy group preferably have 1 to 8 carbon atoms, more preferably 1 to 4 carbon atoms.
  • the substituents may be the same or different.
  • connection part represented by the following formula
  • equation (2) is mentioned.
  • equation (2) (In the formula, 5 ′ represents an oxygen atom of a phosphodiester bond on the 5 ′ side, 3 ′ represents a phosphate atom of a phosphodiester bond on the 3 ′ side, and n represents an integer of 2 or more and 4 or less.
  • l is an integer of 2 or more, and (n + 1) ⁇ l represents an integer of 40 or less.)
  • (n + 1) ⁇ l is preferably 2 or more and 36 or less, and more preferably 3 or more and 16 or less.
  • the same aspect as the substituent in Formula (1) is applied to the substituent of H in Formula (2).
  • linking site examples include the following chain sites.
  • linking site examples include the following chain sites.
  • the first primer has a first identification sequence and a tag sequence, and has a natural base constituting such a base sequence or an artificial base homologous thereto, and allows base pairing with a natural nucleic acid.
  • a main component Typically an oligonucleotide or a derivative thereof.
  • the first primer preferably has a tag sequence, a linking site, and a first identification sequence in that order from the 5 'side.
  • the 5 'end of the nucleotide base adjacent to the 3 ′ side of the ligation site derived from the first primer in the template strand or the base in the vicinity thereof is the 5 ′ end, and the tag sequence in the first primer An amplified fragment having no complementary strand is obtained (see FIGS. 1A and 1B and FIGS. 2A to 2C).
  • a sequence unrelated to the tag sequence or the first identification sequence can also be included in the vicinity of the linking site, that is, on the 3 'side and 5' side of the linking site.
  • the presence of a ligation site can reduce or avoid the influence of unintended DNA extension reaction progress or termination on the tag sequence or the first identification sequence in the extended strand. Because.
  • the second primer includes a second identification sequence that identifies the second base sequence in the target nucleic acid.
  • the lengths and the like of these base sequences are not particularly limited, and are appropriately determined according to the contents of the target sequence of the target nucleic acid.
  • the second identification sequence is a sequence for amplifying the target nucleic acid together with the first primer by nucleic acid amplification, and specifically with the second base sequence constituting the other part of the target sequence in the target nucleic acid. Can hybridize.
  • the second identification sequence is set complementarily to the extent that it can hybridize with the second base sequence with high selectivity. Preferably, it is set to be completely complementary (specific).
  • the labeling substance binding region can be provided with a labeling substance in advance.
  • the labeling substance is for detecting a DNA double-stranded fragment bound to a detection probe on a solid phase.
  • conventionally known substances can be appropriately selected and used. It may be various dyes such as a fluorescent substance that emits a fluorescent signal when excited by itself, or may be a substance that emits various signals in combination with the second component by an enzyme reaction or an antigen-antibody reaction.
  • a fluorescent labeling substance such as Cy3, Alexa555, Cy5, Alexa647 can be used.
  • the labeling substance binding region is provided with a labeling substance linked to the second base sequence directly or via a suitable linker by a known method.
  • the second primer may be configured such that the labeling substance binding region can bind the labeling substance. That is, a labeled probe having a predetermined base sequence and having a labeling substance and a base sequence for identifying the label binding sequence may be capable of binding. Such a labeled probe can be supplied to a DNA double-stranded fragment hybridized with a detection probe on a solid phase in the hybridization step or detection step described later, and can be labeled.
  • the third primer may not have a labeling substance binding region. That is, in the amplification step, nucleic acid amplification is performed using a nucleoside triphosphate including a nucleoside derivative triphosphate provided with a labeling substance, whereby a labeled substance is introduced into the DNA extension site of the amplified fragment and labeled. Because it can be obtained.
  • the second primer has a labeling substance binding region as required in addition to the second identification sequence, and has a natural base constituting the base sequence of the second identification sequence or an artificial base homologous thereto. In addition, it has a skeleton that allows base pairing with natural nucleic acids. Typically an oligonucleotide or a derivative thereof.
  • the labeling substance binding region and the second identification sequence may be directly linked, but it is preferable to have a linking site between them.
  • the labeling substance binding region has a base sequence that interacts with and binds to the labeling probe.
  • the linking site is as described in the first primer.
  • the second primer preferably has a labeling substance binding region, a linking site, and a second identification sequence in that order from the 5 'side.
  • the base binding to the base of the nucleotide adjacent to or adjacent to the 3 ′ side of the linking site derived from the second primer in the template strand is the 5 ′ end, and the label binding region in the second primer A DNA amplified fragment having no complementary strand of (base sequence) is obtained (see FIGS. 1B and 2B).
  • a sequence unrelated to the labeling substance binding region and the second identification sequence can also be included in the vicinity of the linking site, that is, on the 3 ′ side and 5 ′ side of the linking site.
  • the second primer becomes a template strand, due to the presence of the ligation site, the influence of unintended DNA extension reaction progress or termination on the labeling substance binding region or the second identification sequence in the extended strand is reduced or This is because it can be avoided.
  • Such primers can be synthesized according to a normal oligonucleotide synthesis method.
  • the linking site can be synthesized using a phosphoramidite reagent having an alkylene chain.
  • a reagent itself is known and can be obtained from, for example, GlenResearch.
  • the following reagents can be mentioned.
  • DMT represents a typical dimethoxytrityl group as a hydroxyl protecting group, but may be other known hydroxyl protecting groups.
  • PA represents a phosphoramidite group.
  • Nucleic acid amplification is performed using these primers.
  • various known methods can be applied to the nucleic acid amplification method, but typically, various PCRs such as PCR and multiplex PCR are used.
  • a person skilled in the art can appropriately set the solution composition, temperature control, and the like in carrying out the nucleic acid amplification step.
  • the first primer having these in the order of the tag sequence, the linking site and the first identification sequence from the 5 ′ side, and the labeling substance binding region, the linking site and the second from the 5 ′ side.
  • PCR is performed on a sample that may contain a target nucleic acid using a second primer having these in the order of the identification sequences, as shown in each of (a) to (c) of FIG. 1B Due to the DNA extension reaction of DNA polymerase, a template strand containing the primer is formed from the first primer and the second primer.
  • the DNA extension reaction is again performed by the DNA polymerase using the second primer and the first primer which are different from the primers from which the template strands are derived.
  • the DNA extension reaction of the DNA polymerase with respect to the template strand starting from the second primer and containing the first primer is performed by the first primer in the template strand.
  • DNA elongation is suppressed or stopped.
  • the DNA extension reaction of the DNA polymerase with respect to the template strand starting from the first primer and containing the second primer is derived from the second primer in the template strand.
  • the DNA elongation is suppressed or stopped.
  • the resulting amplified fragment has a single-stranded tag sequence protruding from the 5 ′ end and a labeling substance binding region, and includes a first identification sequence and a second identification sequence.
  • a double-stranded DNA fragment comprising a double strand. That is, in the heavy chain fragment of this DNA, the tag sequence protrudes into a single strand on the 5 ′ side of one DNA strand, and the labeling substance binding region protrudes on the 5 ′ side of the other DNA strand. Yes.
  • the labeling substance is attached to the 5 ′ end of one DNA strand as shown in FIG. 2A. It has a tag sequence protruding on the 5 ′ side of one DNA strand, and in the first and second identification sequences, it becomes a DNA double-stranded fragment comprising a double strand.
  • a labeling substance is present at the DNA chain extension site, a tag sequence protrudes on the 5 ′ side of one DNA chain, and the first and second identification sequences are double-stranded.
  • a DNA double-stranded fragment comprising
  • the hybridization step is a step in which the amplified fragment obtained in the amplification step and the detection probe are brought into contact with each other so as to be hybridizable with a tag sequence.
  • the tag sequence of the DNA double-stranded fragment obtained in the amplification step, the detection sequence of the detection probe on the solid phase body, and the fixed sequence When they are complementary to the extent that they can specifically hybridize, they hybridize to form a duplex in a given detection probe on the solid phase.
  • An appropriate washing step may be further included after the hybridization step.
  • a DNA double-stranded fragment corresponding to the target nucleic acid specifically amplified in the amplification step is supplied.
  • This fragment has a tag sequence specific to a detection probe associated in advance as a single strand.
  • a denaturation step such as heat denaturation. Therefore, the hybridization efficiency is high, and as a result, the sensitivity can be improved and stabilized .
  • the sensitivity is preferably improved by a factor of 5 or more, more preferably by a factor of 10 or more by providing a linking site in the first primer.
  • the rapidity of hybridization is also improved. It has been found that the provision of a linking site in the first primer shortens the hybridization time to about 1/10.
  • the DNA double-stranded fragment supplied to the hybridization step has a labeling substance binding region and is directly provided with a labeling substance
  • a special labeling step does not have to be performed.
  • FIG. 2C the same applies to the case where the DNA double-stranded fragment is given a labeling substance by the amplification step.
  • the labeling substance binding region includes a base sequence that binds the labeling probe
  • this base sequence portion projects as a single strand to the 5 ′ side opposite to the tag sequence. . For this reason, it is possible to efficiently hybridize with the labeled probe, and to label quickly, easily and with high sensitivity.
  • the labeled probe is supplied to the solid phase simultaneously with the DNA double strand break in the hybridization step, or before and after the supply of the DNA double strand fragment to the solid phase. (That is, it may be before or after hybridization).
  • the DNA double-stranded fragment hybridizes only to a specific detection probe based on the tag sequence.
  • the detection sequence and the tag sequence of the detection probe are designed to be highly selective and mishybridization is highly suppressed. Hybridization of heavy chain fragments is highly suppressed.
  • the detection step is a step of detecting a hybridized product of the amplified fragment on the solid phase body and the detection probe.
  • the detection step is a step of acquiring signal intensity information about the target nucleic acid based on the labeling substance held by the hybridized product on the solid phase after hybridization, and detecting the hybridized product. For obtaining signal intensity information, a label signal derived from a labeling substance can be detected. Since the position on the solid phase body of the detection probe associated with the target nucleic acid in advance is acquired in advance, the presence or the ratio of the target nucleic acid can be detected by detecting the label signal.
  • a conventionally known method may be appropriately selected and adopted according to the form of the solid phase used and the type of labeling substance.
  • the fluorescent signal of the added labeling substance is detected by an array scanner or the like, or a chemiluminescent reaction to the labeling substance Can be implemented.
  • a detection method using a flow cytometer can be used.
  • the presence or absence, the ratio, etc. of the target nucleic acid in the sample can be detected based on the signal intensity information of the labeling substance. According to this method, even when a plurality of target nucleic acids are detected at the same time, it is possible to reliably detect a target sequence as a detection target. In this method, since the DNA double-stranded fragment obtained in the amplification step is suitable for efficient hybridization and efficient labeling, efficient detection with high sensitivity is possible and a complicated denaturation step is performed. It can be omitted.
  • nucleic acid amplification was performed using a plurality of sets of the first primer and the second primer so that they could be detected by a plurality of detection probes previously associated with a plurality of target nucleic acids, and obtained in the amplification step
  • a plurality of amplified fragments and a plurality of detection probes on the solid phase are brought into contact with each other so as to be able to hybridize, and a hybrid product of the plurality of amplified fragments on the solid phase and the plurality of detection probes is detected. It is preferable.
  • the nucleic acid amplifying agent of the present invention is a first discriminating first base sequence in a nucleic acid to be amplified from a first arbitrary base sequence from the 5 ′ side. And an oligonucleotide derivative having a linking site capable of suppressing or stopping the DNA polymerase reaction between the first base sequence and the first identification sequence.
  • the nucleic acid amplification agent includes such a linking site, the nucleic acid amplification agent is used in the nucleic acid amplification method as at least one primer, and the DNA strand containing the nucleic acid amplification agent obtained by the amplification reaction is a template strand.
  • the linking site acts as a point for suppressing or stopping the DNA polymerase reaction in the extended strand, and the portion after the linking site does not function as a template strand.
  • an extended strand complementary to the template strand after the ligation site is not formed.
  • the resulting DNA double-stranded fragment is a DNA duplex having a single strand of the first arbitrary base sequence on one 5 ′ side, as shown in FIG. 1A.
  • the second primer which is the other primer, is amplified with the second arbitrary base sequence from the 5 ′ side in the same manner as the first primer.
  • an oligonucleotide derivative having a linking site capable of suppressing or stopping the DNA polymerase reaction between the second base sequence and the second identification sequence. it can.
  • a DNA duplex having a single strand of the first arbitrary base sequence and a single strand of the second arbitrary base sequence on each 5 'side is obtained.
  • the nucleic acid amplification agent can typically be used as a primer in various nucleic acid amplification methods.
  • the first arbitrary base sequence and / or the second arbitrary base sequence may be a tag sequence in the present invention, or may be a base sequence to which a label is bound or capable of hybridizing with a labeled probe. Good.
  • the target nucleic acid can be amplified and labeled at the same time.
  • the linking site already described in the present detection method can be applied to the linking site in the nucleic acid amplification agent.
  • the first arbitrary base sequence and the first identification sequence of the nucleic acid amplification site include the tag sequence and the first identification sequence in the first primer and the second primer already described in the detection method, and Various embodiments of the labeling substance binding region and the second identification sequence can be applied. That is, the nucleic acid amplification agent uses the first primer and the second primer as one embodiment.
  • kits containing one or more of these nucleic acid amplification agents is also provided.
  • the kit may contain a solid phase body for hybridization with a DNA fragment obtained using the first primer or the second primer described above.
  • a DNA double-stranded fragment obtained by the present detection method that is, a DNA duplex having a single-stranded portion on the 5 ′ side of at least one strand and having a double-stranded portion by base pairing.
  • At least one DNA strand has a linking site capable of suppressing or stopping a DNA polymerase reaction between the single-stranded portion and the double-stranded binding portion, and the single-stranded portion is A DNA double-stranded fragment having a tag sequence complementary to the base sequence in the detection probe is also provided.
  • a DNA double-stranded fragment having a single-stranded portion on the 5 'side of the other strand and having a label linked to this single-stranded portion is also provided.
  • a probe hybridization composition containing them is also provided. Use this method.
  • a method for amplifying a target nucleic acid in a sample is also provided. That is, a first arbitrary base sequence and a first identification sequence for identifying the first base sequence in the target nucleic acid, and between the first arbitrary base sequence and the first recognition sequence
  • a method is provided which comprises the step of performing nucleic acid amplification of the sample using at least a first primer having a linking site capable of suppressing or stopping the DNA polymerase reaction.
  • the amplified fragment obtained by this method is a DNA double-stranded fragment having a single strand of the first arbitrary base sequence protruding to the 5 'side of at least one strand.
  • the second arbitrary base sequence and a second identification sequence for identifying the second base sequence in the target nucleic acid are included as other primers, and the first arbitrary base A second primer having a linking site capable of suppressing or stopping the DNA polymerase reaction can also be used between the sequence and the first recognition sequence.
  • a DNA double-stranded fragment having a single strand of the first arbitrary base sequence protruding to the 5 'side of both strands can be obtained.
  • the first arbitrary base sequence may be provided with a labeling substance or may have a base sequence capable of binding to the label probe. The same applies to the second primer.
  • the various aspects of the detection method described above can be applied to the first primer, the second primer, and the ligation site.
  • This amplification method is also provided as a method for producing a DNA double-stranded fragment having a single strand on the 5 'side of at least one DNA strand. Furthermore, this amplification method can also be implemented as a method for labeling a target nucleic acid. Furthermore, it can also be implemented as a method for detecting a target nucleic acid comprising such a labeling step. That is, by using this amplification step (labeling step) instead of the labeling step in the detection methods such as SNP disclosed in JP2008-306941A, JP2009-24A and Non-Patent Document 1, Thus, efficient and sensitive hybridization can be carried out.
  • the target nucleic acid was detected by the following procedure according to the detection method of the present invention. Hereinafter, it demonstrates according to these order.
  • DNA microarray GENESHT (Nippon Gaishi Co., Ltd.) uses an aqueous solution in which a synthetic oligo DNA (manufactured by Nippon Genetic Laboratory Co., Ltd.) having a 3 ′ end modified with an amino group is dissolved in a plastic plate as a detection probe. Spotted with a spotter (registered trademark).
  • synthetic oligo DNA sequences used the following 33 types capable of high-speed hybridization were selected from SEQ ID NOs: 1 to 100.
  • the synthetic oligo DNA was immobilized by the procedure described below. That is, after washing with 2 ⁇ SSC / 0.2% SDS for 15 minutes, washing with 2 ⁇ SSC / 0.2% SDS at 95 ° C. for 5 minutes, and then washing with sterilized water (shaking up and down 10 times) 3 Repeated times. Then, it dehydrated by centrifugation (1000 rpm x 3 minutes).
  • the genomic DNA used for amplification is derived from humans and is specific to six target nucleic acids ((1) to (6)) in the human genome.
  • Primers P1-1 to P1 shown in the following table -6 (manufactured by Nippon Genetic Institute), P2-1 to P2-6 (manufactured by Nippon Genetic Institute) and P3-1 to P3-6 (manufactured by Nippon Genetic Institute) were prepared. Each series has the following configuration (displayed as 5 ′ to 3 ′).
  • the propylene group portion of the P3-based primer was synthesized according to an ordinary oligonucleotide synthesis method using Spacer Phophoamidite C3, a phosphoramidite reagent of GlenResearch, shown in the following formula.
  • P1-based primers F, R: P2-based primers including a base sequence for specific target nucleic acids (1) to (6) in human DNA:
  • P3 primer F: Binding sequence of labeled probe + base sequence for each target nucleic acid of P1 system
  • R Tag sequence consisting of a base sequence complementary to the base sequence of the synthetic oligonucleotide probe + linkage site (propylene chain) + base sequence for each target nucleic acid of P1 system
  • genomic DNA was amplified using these primers as follows.
  • QIAGEN's multiplex PCR master mix was used as a sample amplification reagent.
  • Applied Biosystems GeneAmp PCR 9970 was used as a thermal cycler.
  • the reagent preparation is then transferred to a thermal cycle plate and the thermal cycle reaction (after 15 minutes at 95 ° C .; 30 seconds at 95 ° C., 1 second at 80 ° C., 40 cycles of 6 minutes at 64 ° C., then lowered to 10 ° C.) Went.
  • the amplified labeled sample was purified by QIAGEN's MinElute PCR-Purification-Kit, and then confirmed to be amplified by the intended length by agarose electrophoresis. The results are shown in FIG. The upper part of FIG. 3 shows the result of electrophoresis, and the lower part shows the amplification amount calculated from the fluorescence intensity.
  • Hybridization In order to hybridize the amplified sample obtained in (2) with the detection probe immobilized on the microarray, the following Hybri control and Hybri solution were prepared, and a reagent for hybridization was prepared therefrom.
  • PrimerMix includes a labeling probe (fluorescently modified oligonucleotide that binds to the 5 ′ side of F of P2 and P3 primers).
  • the Alexa555-rD1_100 used for the Hybri control was one in which the 5 'end of a sequence complementary to the corresponding sequence of D1_100 was labeled with Alexa555.
  • Hybri solution 20 x SSC 2.0ml 10% SDS 0.8ml 100% Formamide 12.0ml 100 mM EDTA 0.8 ml milliQ 24.4ml Total 40.0ml
  • Hybri control 1.5 ⁇ l Primer Mix 1.0 ⁇ l Hybri solution 9.0 ⁇ l Subtotal 10.5 ⁇ l Amplified sample 3.0 ⁇ l 18.0 ⁇ l total
  • the microarray substrate after completion of the hybridization reaction is immersed in a glass staining vat filled with a cleaning solution of the following composition, shaken up and down for 5 minutes, and transferred to a glass staining vat containing sterilized water, The mixture was shaken up and down for 1 minute and centrifuged at 2000 rpm for 1 minute to remove water remaining on the surface of the microarray substrate.
  • composition of cleaning solution milliQ 188.0ml 20 x SSC 10.0ml 10% SDS 2.0ml Total 200.0ml
  • the intended target nucleic acid in the genomic DNA can be amplified regardless of the presence or absence of the tag sequence.
  • the lower table of FIG. 3 it was found that there was no significant change in the amplification amount even when the tag sequence was directly linked to the identification sequence or via a linking site containing a propylene group. .
  • the use of the P3-based primer improves the detection sensitivity by at least 10 times.
  • the amplification sample was applied to the array without performing the denaturation step, and as shown in FIG. 3, the synthesis amount of the amplification sample was almost the same as that by the P2-based primer. From the above, it can be seen that a double-stranded fragment with high efficiency and good label efficiency was obtained by using the P3 primer.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Cette invention concerne un procédé de détection d'un acide nucléique cible, qui permet une hybridation de sonde efficace. Dans la présente invention, un acide nucléique cible est amplifié à l'aide d'une première amorce et d'une seconde amorce, un fragment amplifié et une sonde de détection qui est préalablement associée à l'acide nucléique cible sont mis en contact l'un avec l'autre de façon que le fragment amplifié et la sonde de détection puissent s'hybrider l'un à l'autre, et le produit de l'hybridation est détecté. La première amorce contient une séquence étiquette complémentaire de la sonde de détection et une première séquence de reconnaissance capable de reconnaître une première séquence de nucléotides dans l'acide nucléique cible et contient, entre la séquence étiquette et la première séquence de reconnaissance, un site de liaison capable d'inhiber ou d'arrêter une réaction de l'ADN polymérase, et la seconde amorce contient une seconde séquence de reconnaissance capable de reconnaître une seconde séquence de nucléotides dans l'acide nucléique cible.
PCT/JP2011/071048 2011-09-14 2011-09-14 Procédé de détection d'un acide nucléique cible WO2013038534A1 (fr)

Priority Applications (17)

Application Number Priority Date Filing Date Title
PCT/JP2011/071048 WO2013038534A1 (fr) 2011-09-14 2011-09-14 Procédé de détection d'un acide nucléique cible
JP2013533406A JP5932808B2 (ja) 2011-09-14 2011-09-14 標的核酸の検出方法
JP2012173333A JP6182300B2 (ja) 2011-09-14 2012-08-03 標的核酸の検出方法
JP2012173361A JP2013059320A (ja) 2011-09-14 2012-08-03 標的核酸の検出方法
JP2012175283A JP6001374B2 (ja) 2011-09-14 2012-08-07 標的核酸の検出方法及びそれに用いるキット
ES12832061T ES2736977T3 (es) 2011-09-14 2012-09-14 Método para detectar ácido nucleico diana
JP2012549585A JP5503021B2 (ja) 2011-09-14 2012-09-14 標的核酸の検出方法
EP12832061.1A EP2762562B1 (fr) 2011-09-14 2012-09-14 Procédé de détection d'un acide nucléique cible
SG11201400635UA SG11201400635UA (en) 2011-09-14 2012-09-14 Method for detecting target nucleic acid
PCT/JP2012/073710 WO2013039228A1 (fr) 2011-09-14 2012-09-14 Procédé de détection d'un acide nucléique cible
CN201280045065.7A CN103797119B (zh) 2011-09-14 2012-09-14 靶核酸的检测方法
MYPI2014000740A MY157586A (en) 2011-09-14 2012-09-14 Method for detecting target nucleic acid
JP2014023882A JP6076273B2 (ja) 2011-09-14 2014-02-10 標的核酸の検出方法
US14/208,070 US20140206567A1 (en) 2011-09-14 2014-03-13 Method for Detecting Target Nucleic Acid
US15/820,798 US20180119211A1 (en) 2011-09-14 2017-11-22 Method for Detecting Target Nucleic Acid
JP2018073278A JP2018143245A (ja) 2011-09-14 2018-04-05 標的核酸の検出方法
JP2021051302A JP2021100429A (ja) 2011-09-14 2021-03-25 標的核酸の検出方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2011/071048 WO2013038534A1 (fr) 2011-09-14 2011-09-14 Procédé de détection d'un acide nucléique cible

Publications (1)

Publication Number Publication Date
WO2013038534A1 true WO2013038534A1 (fr) 2013-03-21

Family

ID=47882793

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2011/071048 WO2013038534A1 (fr) 2011-09-14 2011-09-14 Procédé de détection d'un acide nucléique cible

Country Status (2)

Country Link
JP (4) JP5932808B2 (fr)
WO (1) WO2013038534A1 (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013162026A1 (fr) * 2012-04-27 2013-10-31 株式会社カネカ Procédé d'amplification d'acide nucléique et procédé de détection d'acide nucléique amplifié
WO2015076356A1 (fr) * 2013-11-22 2015-05-28 株式会社カネカ Méthode de détection d'arn à chaîne courte
JP5967785B2 (ja) * 2013-07-24 2016-08-10 日本碍子株式会社 標的核酸の検出方法
WO2018038232A1 (fr) * 2016-08-24 2018-03-01 国立大学法人東北大学 Procédé de production d'un produit d'amplification d'un acide nucléique cible et utilisation dudit procédé
US9920356B2 (en) 2010-11-24 2018-03-20 Kaneka Corporation Amplified nucleic acid detection method and detection device
FR3102240A1 (fr) 2019-10-18 2021-04-23 Safran Electronics & Defense Capteur à compensation mécanique de l’anisotropie de fréquence
WO2021132596A1 (fr) * 2019-12-27 2021-07-01 株式会社カネカ Ensemble d'amorces et procédé de détection d'acide nucléique cible l'utilisant

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6387606B2 (ja) * 2013-11-27 2018-09-12 東ソー株式会社 核酸の検出方法
US20170260568A1 (en) * 2014-12-15 2017-09-14 Fondazione Istituto Italiano Di Tecnologia Method For The Colorimetric Detection Of The Amplification Of A Target Nucleic Acid Sequence
JP6977978B2 (ja) * 2016-01-28 2021-12-08 株式会社Tba 標的核酸の検出方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992008728A1 (fr) * 1990-11-08 1992-05-29 Hybridon, Inc. Incorporation de groupes reporter multiples sur des oligonucleotides synthetiques
WO1997024455A2 (fr) * 1996-01-03 1997-07-10 Clontech Laboratories, Inc. PROCEDES ET COMPOSITIONS DE CLONAGE D'ADNc ENTIER
WO2003050305A1 (fr) * 2001-12-08 2003-06-19 Seegene, Inc. Amorce de commande de renaturation et ses utilisations
WO2004039825A2 (fr) * 2002-10-30 2004-05-13 Nuevolution A/S Codage enzymatique

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8920097D0 (en) * 1989-09-06 1989-10-18 Ici Plc Amplification processes
JP2004187607A (ja) * 2002-12-12 2004-07-08 Olympus Corp 核酸増幅産物に関する情報を得る方法
WO2006071770A2 (fr) * 2004-12-23 2006-07-06 I-Stat Corporation Systeme et procedes de diagnostic moleculaire
JPWO2006095550A1 (ja) * 2005-03-04 2008-08-14 国立大学法人京都大学 Ｐｃｒプライマー、それを利用したｐｃｒ法及びｐｃｒ増幅産物、並びにｐｃｒ増幅産物を利用するデバイス及びｄｎａ−タンパク複合体
WO2007041201A2 (fr) * 2005-10-03 2007-04-12 Applera Corporation Compositions, procedes et kits pour l'amplification d'acides nucleiques
AU2010328226A1 (en) * 2009-12-07 2012-06-28 Prognosys Biosciences, Inc. Peptide display arrays
SG190377A1 (en) * 2010-11-24 2013-06-28 Kaneka Corp Amplified nucleic acid detection method and detection device

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992008728A1 (fr) * 1990-11-08 1992-05-29 Hybridon, Inc. Incorporation de groupes reporter multiples sur des oligonucleotides synthetiques
WO1997024455A2 (fr) * 1996-01-03 1997-07-10 Clontech Laboratories, Inc. PROCEDES ET COMPOSITIONS DE CLONAGE D'ADNc ENTIER
WO2003050305A1 (fr) * 2001-12-08 2003-06-19 Seegene, Inc. Amorce de commande de renaturation et ses utilisations
WO2004039825A2 (fr) * 2002-10-30 2004-05-13 Nuevolution A/S Codage enzymatique

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9920356B2 (en) 2010-11-24 2018-03-20 Kaneka Corporation Amplified nucleic acid detection method and detection device
US10829805B2 (en) 2010-11-24 2020-11-10 Kaneka Corporation Amplified nucleic acid detection method and detection device
US9783844B2 (en) 2012-04-27 2017-10-10 Kaneka Corporation Method for amplifying nucleic acid and method for detecting amplified nucleic acid
WO2013162026A1 (fr) * 2012-04-27 2013-10-31 株式会社カネカ Procédé d'amplification d'acide nucléique et procédé de détection d'acide nucléique amplifié
JP2018038406A (ja) * 2012-04-27 2018-03-15 株式会社カネカ 核酸の増幅方法、および、増幅核酸の検出方法
JP5967785B2 (ja) * 2013-07-24 2016-08-10 日本碍子株式会社 標的核酸の検出方法
US10392652B2 (en) 2013-11-22 2019-08-27 Kaneka Corporation Micro RNA detection method using two primers to produce an amplified double stranded DNA fragment having a single stranded region at one end
WO2015076356A1 (fr) * 2013-11-22 2015-05-28 株式会社カネカ Méthode de détection d'arn à chaîne courte
WO2018038232A1 (fr) * 2016-08-24 2018-03-01 国立大学法人東北大学 Procédé de production d'un produit d'amplification d'un acide nucléique cible et utilisation dudit procédé
FR3102240A1 (fr) 2019-10-18 2021-04-23 Safran Electronics & Defense Capteur à compensation mécanique de l’anisotropie de fréquence
CN114599935A (zh) * 2019-10-18 2022-06-07 赛峰电子与防务公司 带有用于频率各向异性的机械补偿的传感器
WO2021132596A1 (fr) * 2019-12-27 2021-07-01 株式会社カネカ Ensemble d'amorces et procédé de détection d'acide nucléique cible l'utilisant
JP7651477B2 (ja) 2019-12-27 2025-03-26 株式会社カネカ プライマーセット及びそれを用いて標的核酸を検出する方法

Also Published As

Publication number Publication date
JP2013059319A (ja) 2013-04-04
JP6001374B2 (ja) 2016-10-05
JP6182300B2 (ja) 2017-08-16
JPWO2013038534A1 (ja) 2015-03-23
JP2013059320A (ja) 2013-04-04
JP5932808B2 (ja) 2016-06-08
JP2013059321A (ja) 2013-04-04

Similar Documents

Publication Publication Date Title
JP5932808B2 (ja) 標的核酸の検出方法
AU2017203349B2 (en) Compositions of toehold primer duplexes and methods of use
JP6076273B2 (ja) 標的核酸の検出方法
JP5663491B2 (ja) 標的核酸の検出方法
JP5735213B2 (ja) 核酸分子の作製法
EP3055430B1 (fr) Procédé pour détecter des acides nucléiques cibles
JP6196611B2 (ja) 標的核酸の検出方法
JP6321318B2 (ja) 標的核酸の検出方法
JP5613160B2 (ja) ゲノムｄｎａ中の標的配列の検出又は解析方法
JP5165936B2 (ja) 標的核酸中の変異の検出方法及びアレイ
JP6202455B2 (ja) 標的核酸の検出方法
JP2010172323A (ja) 一塩基多型の検出方法
KR20100082214A (ko) 표적 핵산의 서열을 분석하는 방법 및 표적 핵산의 서열을 분석하기 위한 키트
Kamau-Gatogo Development of RNA microchip for pathogen and cancer direct detection
JP2007075052A (ja) 単一蛍光標識オリゴヌクレオチドを用いた核酸の検出法
Nilsson et al. Application of Padlock and Selector Probes in Molecular Medicine

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11872283

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2013533406

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11872283

Country of ref document: EP

Kind code of ref document: A1

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载